Are You Really Allergic to Penicillin? (Update)

What It Covers

Roughly 10% of Americans carry a penicillin allergy label in their medical records, but fewer than 1% are genuinely allergic. Freakonomics Radio host Stephen Dubner shares his personal experience getting delabeled, while allergists Kimberly Blumenthal and Elena Resnick explain the medical, economic, and public health consequences of this widespread misdiagnosis affecting over 30 million people.

Key Questions Answered

• •Penicillin allergy false positive rate: 90% of people labeled penicillin-allergic can actually tolerate it safely. In allergist Kimberly Blumenthal's clinical practice spanning over a decade and roughly 3,000 patients, only approximately 20 showed genuine allergic reactions. The national delabeling rate sits below 1%, while hospitals with active protocols have achieved 9% — revealing a massive, addressable gap in standard care.
• •Delabeling process: Getting cleared of a penicillin allergy label involves three sequential steps: a skin prick test, an intradermal test, and finally an oral amoxicillin challenge with two hours of monitored observation. If both skin tests are negative, there is a 95%+ likelihood of passing the oral challenge. The entire process is conducted in an allergist's office and takes two separate visits.
• •Mortality risk of mislabeling: A Blumenthal-led study comparing 60,000 penicillin-labeled patients against 200,000 unlabeled patients found a 14% increase in all-cause mortality among the labeled group. The mechanism involves being prescribed less effective, more toxic, and more expensive alternative antibiotics — which carry higher risks of C. difficile infection, antibiotic resistance, surgical complications, and kidney failure.
• •Allergy vs. intolerance distinction: A true allergy requires immune cell involvement — specifically IgE antibodies triggering reactions against harmless substances. Conditions like lactose intolerance mimic mild allergy symptoms (stomach upset, bloating) but involve no immune response and cannot escalate to anaphylaxis. Misattributing intolerances or drug side effects as allergies is a primary driver of false allergy labels, particularly in childhood.
• •Childhood misattribution mechanism: Children frequently develop rashes during infections. When those infections are treated with antibiotics like amoxicillin, the rash gets attributed to the drug rather than the underlying illness — often a viral infection that antibiotics cannot treat. Pediatricians and parents rushing to treat fevers with antibiotics, then misreading the resulting rash as a drug reaction, is the dominant origin story for penicillin allergy labels.
• •Allergy research funding gap: NIH funded its first penicillin allergy research grant in 30 years only recently, with Blumenthal as the recipient. Allergy sits at the bottom of medical research funding hierarchies, below neurosurgery and cardiology. Pharmaceutical companies fund large controlled trials focused on treatments rather than root causes, while tick-bite allergy research recently received $100 million in congressional funding due to its political relatability.